Inclusion and exclusion criteria for epilepsy clinical trials-Recommendations from the April 30, 2011 NINDS workshop

Evan Fertig, Brandy E. Fureman, Gregory K Bergey, Mary Ann Brodie, Dale C. Hesdorffer, Deborah Hirtz, Eric H Kossoff, W. Curt LaFrance, Mark Versavel, Jacqueline French

Research output: Contribution to journalArticle

Abstract

On April 30th, 2011 the National Institute of Neurological Disorders and Stroke (NINDS) held a workshop to identify key problems in recent epilepsy clinical trials and propose approaches to address the barriers that impede development of new therapeutic options for epilepsy. Preliminary recommendations were made for selection criteria for subjects entered into epilepsy trials that maximize the scientific impact of the trial and increase the ability to recruit appropriate subjects efficiently and safely. These recommendations were further refined by the authors following the workshop, and subsequently shared with all NINDS workshop participants and with the participants of the 2011 AED XI workshop on epilepsy trials (approximately 200 participants) for further comment. The working group agreed to a final set of criteria that include updated considerations of subject age, clinical semiology, EEG and imaging results, use of prior and current therapies, co-occurring conditions, and suicidality, among others.

Original languageEnglish (US)
Pages (from-to)825-832
Number of pages8
JournalEpilepsy Research
Volume108
Issue number5
DOIs
Publication statusPublished - 2014

    Fingerprint

Keywords

  • Clinical trial methodology
  • Comorbidity
  • Participant selection criteria
  • Recruitment

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this